Use of etiotropic and pathogenetic medicines for COVID-19 in patients with renal failure and/or on dialysis
Impaired kidney function may influence pharmacokinetics of most of the drugs, including the ones used in COVID-19. In this publication, the most important pharmacokinetic parameters and dose adjustment approaches are provided, based on The Renal Drug Handbook и Sanford Guide. In the majority of case...
Main Authors: | V. M. Tsvetov, I. N. Sychev, D. A. Sychev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2020-10-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/524 |
Similar Items
-
Sakharnyy diabet i peritoneal'nyy dializ
by: V M Ermolenko, et al.
Published: (2001-09-01) -
IR-Photometry Method for Measuring Glucose Concentration in Peritoneal Dialysis Fluid
by: N. M. Zhilo, et al.
Published: (2021-09-01) -
RESULTS OF THE PHARMACOECONOMIC STUDY OF MEDICAL CARE FOR END-STAGE RENAL FAILURE PATIENTS IN NEED OF DIALYSIS
by: G. T. Abdrashitova, et al.
Published: (2019-01-01) -
EXPERIENCE OF TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE USING THE METHOD OF PERITONEAL DIALYSIS
by: Татьяна Владимировна Мироненко, et al.
Published: (2021-11-01) -
Lercanidipine in patients with chronic renal failure: the ZAFRA Study
by: N. R. Robles, et al.
Published: (2010-08-01)